Saturday, February 21, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

In Countries More Biased Against Women, Higher COVID-19 Death Rates for Men Might Not Tell an Accurate Story

Daily Remedy by Daily Remedy
February 16, 2022
in Politics & Law
0
In countries more biased against women, higher COVID-19 death rates for men might not tell an accurate story

Yeva Aleksanyan, Colorado State University and Jason Weinman, University of Colorado Anschutz Medical Campus

Pandemics and recessions have the potential to exacerbate existing health inequalities between men and women.

Many social factors can put women at a higher risk of infection during a pandemic. In almost all societies, women assume the role of primary caregiver when family members fall ill. They are also more likely to be front-line health care workers.

Despite this increased exposure to infection, the Ebola and Zika outbreaks highlighted how women are more likely to experience unequal access to resources and health care, and have limited decision-making power about their own health and finances.

COVID-19 is no different. We are researchers in economics and health, and our recent study found that COVID-19 cases and deaths among women may be underreported in countries with higher gender discrimination.

Health care worker wearing a headscarf looking through a medical supply drawer in an ICU.
Although women are more likely to be exposed to COVID-19 as caregivers, they are less likely to be able to access health care for themselves.
Mazen Mahdi/AFP via Getty Images

Gender differences in COVID-19 rates

To investigate the effect of the COVID-19 pandemic on gender-based health disparities, we examined male and female COVID-19 case and death rates across 133 countries from 2020 to 2021. We used data from Global Health 50/50, an organization that tracks COVID-19 cases and deaths by gender worldwide.

We found that most countries, such as the United States, Netherlands, France, Ukraine and Armenia, report roughly equal or slightly higher female infection rates. But 14% of the countries we examined reported over 65% of their COVID-19 cases and deaths were among men. For instance, 88% and 85% of confirmed COVID-19 cases in Bahrain and Qatar, respectively, were among men. Similarly, over 74% of total COVID-19 deaths in Chad, Bangladesh, Malawi and Pakistan were among men.

But what caused these rate differences across countries? We considered both biological factors, like gender differences in healthy life expectancy and death rates from chronic and infectious diseases, and social factors, like employment rates and gender norms. We assessed gender norms using publicly available indices measuring how countries are performing in women’s peace and security, financial inclusion, access to resources and status in the family household.

We found that biological differences, which should result in more consistent case and death rates across locations, couldn’t account for these trends alone. Instead, social factors like higher gender discrimination within the family and limited access to wealth and education were significantly associated with larger differences in male and female COVID-19 case and death rates.

Accounting for gender in health

Gender norms play a role in what opportunities and resources are available for different people. Women often fall through the cracks of the health care system due to gender bias and their poorer socioeconomic status. In many developing countries, women resort to informal, unlicensed health care providers and low-cost medicines, while men spend a greater share of family resources on their own health needs. And in some parts of the world, a woman’s husband or father must provide consent before she can obtain health care treatment.

When women have less independence and decision-making power over their lives, they need to rely on their family members to access health care. In societies where women are devalued and do not have decision-making power, a household may prioritize spending their resources on men’s COVID-19 testing and hospital stays. Thus, we hypothesize that countries are reporting higher male COVID-19 cases and deaths due to underreporting of women’s cases and deaths.

Parent and child walking together holding hands under an umbrella.
In some families, the health of males is prioritized over females.
Xinhua News Agency via Getty Images

This underreporting extends in other areas as well. For example, our data source does not account for transgender and nonbinary people. And country-level data on gender differences in medical access for other diseases and treatments is also unavailable. The World Health Organization’s European office has urged countries to collect gender data through their health information systems. While efforts have been made to improve data collection across health care systems globally, collecting reliable data remains challenging.

Though our findings do show a strong association between gender norms and COVID-19 health disparities, they do not prove causation as a controlled experiment would. Such studies, however, are not possible during a pandemic. And results may vary regionally due to cultural and social differences. One recent study, for example, found that more men in the U.S. die from COVID-19 than women because they are less likely to follow mask and social distancing guidelines.

Despite these limitations, it is clear that social factors play a role in COVID-19 health outcomes. Ignoring gender bias in health care has the potential to exacerbate long-standing inequities that existed prior to the pandemic.

[Get the best of The Conversation, every weekend. Sign up for our weekly newsletter.]

Yeva Aleksanyan, Ph.D. Candidate in Economics, Colorado State University and Jason Weinman, Associate Professor of Radiology, University of Colorado Anschutz Medical Campus

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Prevention Gap in Dementia Care

    The Prevention Gap in Dementia Care

    0 shares
    Share 0 Tweet 0
  • Healthcare in Space

    1 shares
    Share 0 Tweet 0
  • Healthcare Natural Rights

    0 shares
    Share 0 Tweet 0
  • Heat Safety Tips Every Pregnant Mother Should Know

    0 shares
    Share 0 Tweet 0
  • What is the 411 on the New 988 Hotline?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy